Researchers have developed a non-genetically modified cell engineering approach that rethinks how viruses are grown for animal vaccines. The team screens thousands of cells to identify natural high performers and optimizes culture conditions to create stable, high-efficiency virus “factories”.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.